Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Inventory Average (2016 - 2025)

Historic Inventory Average for United Therapeutics (UTHR) over the last 16 years, with Q3 2025 value amounting to $172.8 million.

  • United Therapeutics' Inventory Average rose 2206.92% to $172.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $172.8 million, marking a year-over-year increase of 2206.92%. This contributed to the annual value of $134.8 million for FY2024, which is 2614.59% up from last year.
  • Latest data reveals that United Therapeutics reported Inventory Average of $172.8 million as of Q3 2025, which was up 2206.92% from $167.3 million recorded in Q2 2025.
  • United Therapeutics' Inventory Average's 5-year high stood at $172.8 million during Q3 2025, with a 5-year trough of $89.0 million in Q2 2022.
  • Over the past 5 years, United Therapeutics' median Inventory Average value was $102.9 million (recorded in 2023), while the average stood at $115.4 million.
  • Its Inventory Average has fluctuated over the past 5 years, first plummeted by 361.38% in 2021, then soared by 4095.33% in 2024.
  • Over the past 5 years, United Therapeutics' Inventory Average (Quarter) stood at $95.2 million in 2021, then rose by 1.31% to $96.5 million in 2022, then rose by 11.97% to $108.0 million in 2023, then surged by 40.95% to $152.3 million in 2024, then rose by 13.49% to $172.8 million in 2025.
  • Its Inventory Average was $172.8 million in Q3 2025, compared to $167.3 million in Q2 2025 and $161.6 million in Q1 2025.